BBlogFlow

3 US Healthcare Stocks Riding Strong Demand For Care - Simply Wall Street

·Oct 3, 2026
Source: Simply Wall Street
Read the original article

This story deserves to be shared

Send it to someone who'd care, or post it on your networks.

Facebook Twitter Email

Hiring is cooling, pay packets are barely keeping up with prices, yet healthcare is still adding jobs and attracting capital. That mix can punish companies tied to discretionary spending while creating pockets of resilience where medical demand keeps ticking over. This article walks through three U. S. Healthcare Employment & Services Beneficiaries screener stocks exposed to that jobs data and explains how the same report can signal opportunity or caution depending on the business model. The stocks covered below are just a sample, and the full screen surfaced 26 more U. S. healthcare providers and services with equally compelling narratives that are not discussed in this article. To identify and analyze your own highest conviction angles across this theme, head straight to the U. S. Healthcare Employment & Services Beneficiaries screener. U. S. Physical Therapy (USPH) U. S. Physical Therapy plugs directly into the healthcare employment theme, running outpatient rehab clinics and workplace injury prevention services that depend on hiring therapists and clinic staff to keep patient volumes and employer contracts flowing. U. S.

This article is an excerpt. To read the full content, visit the original source. Simply Wall Street

Reactions

0 comments

No comments yet. Be the first to share your thoughts!

Facebook Twitter

Related articles

Patient-centered financial navigation assistance helps reduce financial toxicity among cancer patients - Medical Xpress

Among cancer patients, the high financial cost of cancer care is a prevalent problem. This financial burden is also associated with potentially harmful behavioral strategies that patients might use to cope with costs, such as delaying or forgoing treatment and skipping medications. Collectively, researchers refer to this impact as financial toxicity.

Medical Xpress·

Continuous glucose monitors help type 2 diabetes patients spend 5 more hours a day in healthy blood sugar range - Medical Xpress

Continuous glucose monitors (CGMs) could transform diabetes management for millions of Americans with type 2 diabetes who don't take insulin, according to findings published in the New England Journal of Medicine. The clinical trial found that adults using CGMs spent approximately five additional hours each day within their target blood sugar range compared with those receiving routine care. Nearly twice as many CGM users also achieved an A1c level below 7%, a common treatment goal for people with diabetes.

Medical Xpress·

Kefah Mokbel: Can Whole-Genome Sequencing-Based ctDNA Monitoring Help Personalize Adjuvant Treatment? - Oncodaily

“Beyond Detecting Cancer Recurrence: Can Whole-Genome Sequencing-Based ctDNA Monitoring Help Personalize Adjuvant Treatment? An exciting new study published in The Oncologist highlights the clinical potential of Signatera Genome, a whole-genome sequencing (WGS)-based, tumor-informed circulating tumor DNA (ctDNA) assay, not only for detecting molecular residual disease (MRD), but also for potentially informing adjuvant treatment decisions.

Oncodaily·